CRM · Salesforce, Inc.
10-Q filed 2026-05-28 period 2026-04-30
84 Strong
confidence high · source filing on SEC.gov ↗
- Executed a massive $25 billion Accelerated Share Repurchase (ASR) program in March 2026, funded by a $24.8 billion debt offering that significantly increased total leverage.
- Realigned product architecture and revenue reporting into two new categories: 'Agentforce Apps' and 'Data 360, Headless Platform, and Other' to reflect the transition to autonomous AI agents.
- Successfully integrated Informatica (acquired November 2025), which contributed $444 million to total revenues in the first quarter of fiscal 2027.
Filing Health Score pillars
Profitability 25%
85
Revenue grew 13 percent year-over-year to $11.1 billion, and operating margin expanded to 21 percent from 20 percent in the prior year period, demonstrating positive operating leverage (MD&A Results of Operations).
Balance sheet 20%
70
While cash and marketable securities are solid at $11.8 billion, total debt surged to $39.3 billion following a $24.8 billion debt issuance in March 2026, and the current ratio stands at 0.79 due to high unearned revenues (Condensed Consolidated Balance Sheets).
Cash generation 20%
95
Operating cash flow was outstanding at $6.7 billion, representing over 3x net income conversion, while capex intensity remained very low at 1.3% of revenue, yielding a free cash flow margin of nearly 59% (Condensed Consolidated Statements of Cash Flows).
Risk flags 20%
85
No going-concern or restatement issues are present, but the company highlights heightened operational risks from integrating recent acquisitions (Informatica, Qualified) and evolving cybersecurity threats accelerated by AI (Item 1A. Risk Factors).
Mgmt signal 15%
88
Management signals strong strategic momentum by reorganizing its revenue reporting around the new 'Agentforce' AI architecture and executing a massive $25 billion share repurchase program (MD&A Overview).
Key metrics (Three Months Ended April 30, 2026)
net income: $2,107 million
cash and equivalents: $8,935 million
total debt: $39,280 million
shares outstanding: 819 million shares (excluding treasury shares)
revenue: $11,133 million
period: Three Months Ended April 30, 2026
operating cash flow: $6,701 million
Gemma triage notes (pre-analysis, second opinion)
None for this filing.Automated research summaries derived from SEC filings. Not investment advice.